Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Spano

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Scientific Reports|May 11, 2019
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncologyOlivia Candini, Giulia Grisendi, Elisabetta Manuela Foppiani, et al.
Glia|June 2, 2016
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticusJonathan Vinet, Ilia D Vainchtein, Carlotta Spano, et al.
Blood|May 13, 2009
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablationMassimo Dominici, Valeria Rasini, Rita Bussolari, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Stem Cells (Dayton, Ohio)|November 28, 2014
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesisOlivia Candini, Carlotta Spano, Alba Murgia, et al.
Cytotherapy|April 3, 2023
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cellsGiulia Casari, Massimiliano Dall'Ora, Aurora Melandri, et al.
Translational Oncology|October 14, 2021
Anti-GD2 CAR MSCs against metastatic Ewing's sarcomaGiulia Golinelli, Giulia Grisendi, Massimiliano Dall'Ora, et al.
Pathology Oncology Research : POR|September 26, 2006
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondriaKatalin Nagy, Kinga Székely-Szüts, Kamel Izeradjene, et al.
American Journal of Cancer Research|October 18, 2021
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinomaMassimiliano Dall'Ora, Giulia Rovesti, Luca Reggiani Bonetti, et al.
Oncotarget|April 19, 2017
GD2 expression in breast cancerGiulia Orsi, Monica Barbolini, Guido Ficarra, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 11, 2019
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncologyOlivia Candini, Giulia Grisendi, Elisabetta Manuela Foppiani, et al.
Glia|June 2, 2016
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticusJonathan Vinet, Ilia D Vainchtein, Carlotta Spano, et al.
Blood|May 13, 2009
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablationMassimo Dominici, Valeria Rasini, Rita Bussolari, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Stem Cells (Dayton, Ohio)|November 28, 2014
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesisOlivia Candini, Carlotta Spano, Alba Murgia, et al.
Cytotherapy|April 3, 2023
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cellsGiulia Casari, Massimiliano Dall'Ora, Aurora Melandri, et al.
Translational Oncology|October 14, 2021
Anti-GD2 CAR MSCs against metastatic Ewing's sarcomaGiulia Golinelli, Giulia Grisendi, Massimiliano Dall'Ora, et al.
Pathology Oncology Research : POR|September 26, 2006
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondriaKatalin Nagy, Kinga Székely-Szüts, Kamel Izeradjene, et al.
American Journal of Cancer Research|October 18, 2021
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinomaMassimiliano Dall'Ora, Giulia Rovesti, Luca Reggiani Bonetti, et al.
Oncotarget|April 19, 2017
GD2 expression in breast cancerGiulia Orsi, Monica Barbolini, Guido Ficarra, et al.
Pageof 3